Intrathecal "Microdosing": Reality or Artifact?

Pain Medicine (United States)

Volumn 13, Issue 12, 2012, Pages 1664-1665

  Hayek, Salim M ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; BUPIVACAINE; MORPHINE; OPIATE;

ANALGESIA; CHRONIC PAIN; DOSE RESPONSE; DRUG DOSE; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG WITHDRAWAL; HUMAN; LETTER; LOW DRUG DOSE; MICRODOSING; PAIN; PAIN ASSESSMENT; RETROSPECTIVE STUDY; SCORING SYSTEM; SINGLE DRUG DOSE; SPINAL ANESTHESIA;

EID: 84871397743     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2012.01507.x     Document Type: Letter

References (14)

1. Hamza M, Doleys D, Wells M, etal. Prospective study of 3-year follow-up of low-dose intrathecal opioids in the management of chronic nonmalignant pain. Pain Med 2012;13(10):1304-1313.
2. Krames ES. Intraspinal opioid therapy for chronic nonmalignant pain: Current practice and clinical guidelines. J Pain Symptom Manage 1996;11(6):333-352.
3. Dominguez E, Sahinler B, Bassam D, etal. Predictive value of intrathecal narcotic trials for long-term therapy with implantable drug administration systems in chronic non-cancer pain patients. Pain Pract 2002;2(4):315-325.
4. Kim D, Saidov A, Mandhare V, Shuster A. Role of pretrial systemic opioid requirements, intrathecal trial dose, and non-psychological factors as predictors of outcome for intrathecal pump therapy: One clinician's experience with lumbar postlaminectomy pain. Neuromodulation 2011;14(2):165-175; discussion 175.
5. Grider JS, Harned ME, Etscheidt MA. Patient selection and outcomes using a low-dose intrathecal opioid trialing method for chronic nonmalignant pain. Pain Physician 2011;14(4):343-351.
6. Brodner RA, Taub A. Chronic pain exacerbated by long-term narcotic use in patients with nonmalignant disease: Clinical syndrome and treatment. Mt Sinai J Med 1978;45(2):233-237.
7. Taylor CB, Zlutnick SI, Corley MJ, Flora J. The effects of detoxification, relaxation, and brief supportive therapy on chronic pain. Pain 1980;8(3):319-329.
8. Lord SM, Barnsley L, Bogduk N. The utility of comparative local anesthetic blocks versus placebo-controlled blocks for the diagnosis of cervical zygapophysial joint pain. Clin J Pain 1995;11(3):208-213.
9. Hebl JR, Horlocker TT, Kopp SL, Schroeder DR. Neuraxial blockade in patients with preexisting spinal stenosis, lumbar disk disease, or prior spine surgery: Efficacy and neurologic complications. Anesth Analg 2010;111(6):1511-1519.
10. Horlocker TT, Abel MD, Messick JM, Jr, Schroeder DR. Small risk of serious neurologic complications related to lumbar epidural catheter placement in anesthetized patients. Anesth Analg 2003;96(6):1547-1552, table of contents.
11. Hayek SM, Veizi IE, Narouze SN, Mekhail N. Age-dependent intrathecal opioid escalation in chronic noncancer pain patients. Pain Med 2011;12(8):1179-1189.
12. Hayek SM, Deer TR, Pope JE, Panchal SJ, Patel VB. Intrathecal therapy for cancer and non-cancer pain. Pain Physician 2011;14(3):219-248.
13. Forero M, Chan PS, Restrepo-Garces CE. Successful reversal of hyperalgesia/myoclonus complex with low-dose ketamine infusion. Pain Pract 2012;12(2):154-158.
14. Veizi IE, Hayek SM, Narouze S, Pope JE, Mekhail N. Combination of intrathecal opioids with bupivacaine attenuates opioid dose escalation in chronic noncancer pain patients. Pain Med 2011;12(10):1481-1489.